J&J uses share-the-wisdom approach to spread the word on Prezcobix

Johnson & Johnson ($JNJ) is trying a new tack on the old "talk to your doctor" advice. With a new campaign for its HIV drug Prezcobix, the company is urging potential patients to snap a photo and send it to their physicians to see if the drug is right for them. It's part of an overall push to get people with HIV to share their wisdom about dealing with the disease. Report

Suggested Articles

Hecht recently sat down with Fierce Pharma to discuss how Ora supports their customers and site partners.

Alexion Pharmaceuticals names its first chief diversity officer as the rare disease specialist looks to cultivate diversity and inclusion.

BMS executives pointed to upcoming Opdivo data releases, as well as strong demand for other drugs in the portfolio, as reasons for optimism.